PHS

PFM Health Sciences Portfolio holdings

AUM $988M
1-Year Est. Return 67.93%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+67.93%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$988M
AUM Growth
-$185M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
100
New
Increased
Reduced
Closed

Top Buys

1
+$20.8M
2
+$20.1M
3
+$19.3M
4
SYK icon
Stryker
SYK
+$18.5M
5
UNH icon
UnitedHealth
UNH
+$17.1M

Top Sells

1
+$150M
2
+$55.9M
3
+$38.9M
4
ISRG icon
Intuitive Surgical
ISRG
+$33M
5
COR icon
Cencora
COR
+$25.2M

Sector Composition

1 Healthcare 98.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
THC icon
1
Tenet Healthcare
THC
$20.6B
$79M 8%
397,767
-63,887
LLY icon
2
Eli Lilly
LLY
$884B
$73.4M 7.43%
68,289
-156,850
AXSM icon
3
Axsome Therapeutics
AXSM
$8.3B
$45.9M 4.65%
251,562
-278,770
PEN icon
4
Penumbra
PEN
$13.3B
$45.1M 4.57%
145,171
-49,914
ASND icon
5
Ascendis Pharma
ASND
$14.8B
$37.9M 3.84%
177,685
+32,374
UTHR icon
6
United Therapeutics
UTHR
$21B
$33M 3.34%
67,743
-27,907
CNC icon
7
Centene
CNC
$21.5B
$29.9M 3.02%
725,424
+151,064
BBIO icon
8
BridgeBio Pharma
BBIO
$12.7B
$23.4M 2.37%
306,506
-20,668
ADMA icon
9
ADMA Biologics
ADMA
$3.67B
$23.2M 2.35%
1,270,894
+89,883
NBIX icon
10
Neurocrine Biosciences
NBIX
$12.9B
$23.1M 2.34%
163,197
+105,951
GKOS icon
11
Glaukos
GKOS
$6.26B
$22.8M 2.31%
+201,676
TMO icon
12
Thermo Fisher Scientific
TMO
$186B
$22M 2.22%
37,915
+35,601
EW icon
13
Edwards Lifesciences
EW
$47.4B
$21M 2.13%
246,835
-134,489
ICLR icon
14
Icon
ICLR
$8.19B
$21M 2.13%
115,336
-18,347
INBX icon
15
Inhibrx
INBX
$1.01B
$21M 2.12%
265,517
+25,873
MDT icon
16
Medtronic
MDT
$117B
$20.5M 2.08%
+213,796
NEO icon
17
NeoGenomics
NEO
$1.16B
$19.9M 2.02%
1,694,051
-514,479
MRK icon
18
Merck
MRK
$286B
$19.8M 2%
187,834
-48,634
AMRX icon
19
Amneal Pharmaceuticals
AMRX
$4.17B
$18.5M 1.87%
1,465,480
+1,109,662
SYK icon
20
Stryker
SYK
$140B
$17.9M 1.81%
+50,852
UNH icon
21
UnitedHealth
UNH
$260B
$16.7M 1.69%
+50,539
WAT icon
22
Waters Corp
WAT
$29.7B
$16.4M 1.66%
43,208
+12,457
DXCM icon
23
DexCom
DXCM
$26.2B
$15.1M 1.53%
+227,357
CNTA
24
Centessa Pharmaceuticals
CNTA
$3.84B
$14.8M 1.5%
591,601
-74,595
INDV icon
25
Indivior Pharmaceuticals
INDV
$4.03B
$12.9M 1.31%
360,695
-200,831
1
2 3 4